HOME >> BIOLOGY >> NEWS
Gene's activity points to more lethal subtype of AML

COLUMBUS , Ohio -- A new study shows that the activity of a particular gene can identify people who have a more lethal form of acute myeloid leukemia, singling out those patients who should receive more intense therapy.

The gene, called ERG (for ETS-related gene), has also been linked to chronic leukemia and to breast and prostate cancer.

The findings apply to acute myeloid leukemia (AML) patients with leukemia cells that have normal-looking chromosomes, a feature that occurs in about half of AML patients.

Among these patients, those with leukemia cells showing high ERG activity are almost six times more likely to relapse or die within five years than are patients with low ERG expression following standard therapy.

The Cancer and Leukemia Group B study was initiated by researchers at the Ohio State University Comprehensive Cancer Center, and their findings were published online in the Journal of Clinical Oncology.

Our study shows that high ERG activity predicts a poor prognosis in these patients, even when other molecular markers are taken into consideration, says first author Guido Marcucci, associate professor of internal medicine and an AML specialist at Ohio State's James Cancer Hospital and Solove Research Institute.

The findings mean that these patients require a stem-cell transplant or other aggressive therapy, and that patients with low ERG activity can be treated using standard therapy.

The research confirms a 2005 study led by the same Ohio State researchers in a completely independent set of patients, Marcucci says.

Both studies together further refine the molecular classification of AML in this group of patients and should help us improve treatment outcomes, says principal investigator Clara D. Bloomfield, professor of internal medicine, and an internationally recognized specialist in AML.

About 13,400 new cases of AML are expected this year, and a littl
'"/>

Contact: Darrell E. Ward
Darrell.Ward@osumc.edu
614-293-3737
Ohio State University
9-Jul-2007


Page: 1 2

Related biology news :

1. Genes discovery could help prevent a leading cause of blindness in the elderly
2. Genes mutations found to cause life-threatening aortic disease
3. Prenatal alcohol exposure alters brain activity in the frontal-striatal areas
4. Weizmann Institute scientists develop a general control switch for protein activity
5. Slow wave activity during sleep is lower in African-Americans than Caucasians
6. ChemGenex announces publication confirming activity of Ceflatonin in T315I-Positive CML
7. Neuronal activity gives clues to working memory
8. CSHL links activity in brain synapses and developmental abnormalities with schizophrenia gene
9. Hyperactivity and academic achievement could be linked by genetics
10. Food cue-related brain activity linked to obesity?
11. A relative of anti-aging gene Klotho also influences metabolic activity, obesity

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/10/2019)... ... October 09, 2019 , ... Calcium & Bone Health Institute ... in Vancouver, Canada on September 23-24 for two days. The purpose of symposium ... healthy bone and to prevent calcium-related diseases. The theme of this year was ...
(Date:10/8/2019)... ... October 08, 2019 , ... ... National Research Council of Canada (NRC) to create the Laboratory of Industrial ... and in manufacturing, LIFT will offer a competitive capacity to accelerate the ...
(Date:10/8/2019)... ... October 07, 2019 , ... ... of imaging modalities such as optical projection tomography, optical coherence tomography, echocardiogram, light ... to generate these data sets inhouse, a lot of research groups struggle with ...
Breaking Biology News(10 mins):
(Date:10/3/2019)... ... 2019 , ... Cheyenne is a beautiful and strong Quarter Horse and a ... Rebel’s Run , which offers riding lessons and trail riding in Afton, Virginia. ... Mimi describes her as her “go to horse.” Thus, you can imagine ...
(Date:10/3/2019)... BOSTON (PRWEB) , ... October 03, 2019 , ... Yesterday, ... 2-3, Asymmetrex founder and director, James L. Sherley, M.D., Ph.D., discussed important ... To an attendee audience including both developers and suppliers of clinical trials, in ...
(Date:9/24/2019)... ... September 24, 2019 , ... Personalized ... training and site qualification for clinical trial sites and physician investigators. The ... potential clinical trial participants. , Clinical trial sites are currently located in San ...
(Date:9/17/2019)... , ... September 17, 2019 , ... Tucker, a Labrador ... only four months old, Tucker was limping and lame on his right hip and ... dysplasia and it was called “the worst case the vet had seen.” He was ...
Breaking Biology Technology:
Cached News: